ClinicalTrials.Veeva

Menu

ATOMIC (Active Teens With MultIple sClerosis) Teens: A Feasibility Study

T

The Hospital for Sick Children

Status

Completed

Conditions

Pediatric Multiple Sclerosis

Treatments

Device: ATOMIC mobile app

Study type

Interventional

Funder types

Other

Identifiers

NCT03137602
1000055499

Details and patient eligibility

About

Taking part in recommended levels of physical activity in youth with MS may have an important and positive impact on disease symptoms, long-term disability and health outcomes. Unfortunately, youth with MS are highly inactive. In order to address this issue, the investigators have developed an MS-specific mobile application for teens called Active Teens with Multiple Sclerosis (ATOMIC). In this research the investigators will evaluate the feasibility of using the ATOMIC program in youth with MS. The results of this pilot study will provide the data necessary to ensure the ATOMIC program aligns with the needs of youth with MS.

Enrollment

14 patients

Sex

All

Ages

8 to 25 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. MS diagnosis following standard definitions (IPMSSG);
  2. EDSS <4.0;
  3. Ability to speak English.

Exclusion criteria

  1. Known cardiac disease, including cyanotic congenital heart disease;
  2. inability to understand instructions and tolerate proposed testing or vigorous PA.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

14 participants in 1 patient group

ATOMIC mobile app
Other group
Description:
The proposed ATOMIC intervention consists of four primary components: (a) one-on-one chats with a PA coach, (b) informational posts, (c) PA self-monitoring through an activity tracker and (d) educational modules regarding different aspects of becoming PA delivered through our MS specific PA app.
Treatment:
Device: ATOMIC mobile app

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems